6505--770-25-3-801-0361 -National CMOP MYCOPHENOLATE MOFETIL 250MG CAP -(VA-25-00060549)
ID: 36C77025Q0197Type: Presolicitation
AwardedJun 11, 2025
$106.6K$106,646
AwardeePharmacy Buying Association, Inc. KANSAS CITY 64120
Award #:36C77025P0212
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/298744f1114a4bc6bb191e380f0cd055/view
Timeline
    Description

    The Department of Veterans Affairs is seeking qualified vendors to supply Mycophenolate Mofetil 250mg capsules under solicitation number VA-25-00060549. The procurement requires vendors to submit their quotes, including a signed SF1449 solicitation cover page, an Excel quote spreadsheet, and documentation proving they are authorized dealers or distributors, by April 11, 2025. This pharmaceutical product is critical for patient care within the VA medical system, and all supplies must comply with the Drug Supply Chain Security Act, ensuring quality and traceability. Interested vendors should contact Contract Specialist Larry M Zaritz at larry.zaritz@va.gov for further details and clarification on submission requirements.

    Point(s) of Contact
    Larry ZaritzContracting Officer
    (913) 684-0156
    larry.zaritz@va.gov
    Files
    Title
    Posted
    36C77025Q0197_1.docx
    The Department of Veterans Affairs (VA) announced a presolicitation for the procurement of Mycophenolate Mofetil in both 250mg and 500mg capsules/tablets. The contracting office is seeking to supply these pharmaceuticals to multiple Consolidated Mail Outpatient Pharmacy (CMOP) sites across the country. The solicitation, numbered 36C77025Q0197, has a response deadline of April 10, 2025, and a delivery requirement for various quantities. Interested vendors must ensure their quotations include a signed SF1449 cover page, a completed price schedule, proof of state wholesale distributor licensure, and compliance with the Drug Supply Chain Security Act. The overall goal is to streamline pharmaceutical supply to VA facilities, ensuring adherence to safety standards and regulations. Vendors are advised to monitor Contract Opportunities for updates and to submit their bids via email to the designated contact. This presolicitation emphasizes the VA's commitment to sourcing critical medications while ensuring compliance with regulatory standards.
    36C77025Q0197.docx
    The document outlines a Request for Proposal (RFP) from the Department of Veterans Affairs (VA) for the procurement of Mycophenolate Mofetil in both 250mg capsules and 500mg tablets. The solicitation specifies that quotations must include a signed Standard Form (SF) 1449, a state wholesale distributor license, and a completed Buy American Certificate. The contracting officer requires quotes to be submitted via email by April 10, 2025. Delivery procedures include coordination with designated VA Consolidated Mail Outpatient Pharmacy (CMOP) facilities, with shipping details for various locations included in the schedule. Vendors must comply with the Drug Supply Chain Security Act (DSCSA), ensuring that all pharmaceutical supplies meet labeling and quality standards while facilitating tracking and verification of products. The RFP emphasizes the need for products to be sourced from U.S. manufacturers, include appropriate barcoding, and conform to quality and safety regulations. The government reserves the right to reject any products that do not meet specified conditions. The document is structured to ensure clarity on regulations and requirements for vendors, thus facilitating compliance and efficient procurement processes within the government context.
    52.225-6 TRADE AGREEMENTS CERTIFICATE.docx
    The Trade Agreements Certificate provision outlines the certification requirements for offerors regarding the origin of end products in federal procurements. The offeror must affirm that all products, except those explicitly listed as "other end products," are U.S.-made or from designated countries. The document specifies that any non-compliant items must be detailed by the offeror, including their countries of origin. Evaluations will proceed under established Federal Acquisition Regulation guidelines, ensuring that U.S.-made or designated products are prioritized for contracts unless no suitable offers are available. This provision underscores the government's commitment to leveraging trade agreements while balancing domestic sourcing requirements in federal RFPs, grants, and contracts.
    Pharmaceutical Pricing Schedule MO.xlsx
    The document outlines a Request for Quotation (RFQ) for medical supplies, primarily Mycophenolate Mofetil and Zolpidem Tartrate, to be delivered to the Veterans Affairs (VA) Medical Centers. Vendors must submit their quotes by April 11, 2025, including a signed SF1449 solicitation cover page, an Excel quote spreadsheet, documentation proving they are OEM authorized dealers or distributors, and a Buy American Act certificate. Each vendor is allowed one quote submission, and all items must have at least one year of expiration upon delivery. The procurement prohibits gray market items, mandating that all supplies come from authorized sources to ensure compliance with warranties and service agreements. The required documentation and conditions outline the emphasis on the originality of products, securing health standards, and maintaining a reliable supply chain for the VA. This RFQ is part of a broader series of federal grants and procurement practices aimed at enhancing the quality of care provided by governmental medical facilities.
    Similar Opportunities
    6505--Zonisamide Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers for a Firm Fixed Price, Indefinite-Delivery Requirements contract for Zonisamide Capsules in 25mg, 50mg, and 100mg dosages. Offerors are required to provide pricing for a base year and four option years, submit a 0.5% Cost Recovery Fee, and comply with stringent packaging and barcoding standards, including adherence to the Drug Supply Chain Security Act (DSCSA) and National Drug Code (NDC) requirements. These pharmaceutical products are crucial for the healthcare services provided to veterans and military personnel through the VA and DoD Pharmaceutical Prime Vendor Programs. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details, and ensure they meet all compliance and registration requirements, including current SAM registration.
    6505--36C77026Q0061/RFI/Domestic Sources Rx_MedSurge
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking information from domestic pharmaceutical manufacturers through a Request for Information (RFI) designated 36C77026Q0061, aimed at supporting the Consolidated Mail Outpatient Pharmacy (CMOP) in fulfilling its Open Market (OM) purchasing needs. The RFI seeks to identify both small and large businesses capable of providing a range of pharmaceutical products and ancillary items, with a focus on those manufactured in the United States, to enhance the supply chain for approximately 450,000 prescriptions mailed daily to Veterans. Interested manufacturers are required to submit detailed company and product information, including FDA-approved NDC numbers and operational capabilities, by March 15, 2026, at 4:30 PM CT. For further inquiries, respondents can contact Michael McAlhaney at Michael.McAlhaney@va.gov or (913) 684-1976.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Carbidopa Levodopa Immediate Release (IR) Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care entities, including the VA, Department of Defense (DoD), and Bureau of Prisons (BOP). The procurement will involve awarding a single contract for an initial one-year period, with the possibility of four additional one-year option periods, to maintain an uninterrupted supply of these essential medications. The estimated annual requirements detail various dosages and package sizes, with total usage ranging from 2,008 to 118,764 bottles depending on the item. The solicitation is expected to be released around December 18, 2025, with a closing date of January 8, 2026; interested parties should direct inquiries to Ray Roldan at Raymond.Roldan@va.gov or call 708-786-4930.
    Dimethyl Fumarate DR Presolicitation
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM - 762 TUCSON
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is conducting a Sources Sought Notice to identify potential qualified domestic sources for the procurement of COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM through its National CMOP Office. This announcement serves as a market research tool rather than a solicitation, aiming to gather information on vendors' capabilities to meet the requirements outlined in the Statement of Requirements. The products sought are critical for pharmaceutical preparation and will support the healthcare needs of veterans. Interested vendors must submit their responses, including company details and capability statements, via email to Jennifer Coleman at Jennifer.Coleman4@va.gov by December 19, 2025, at 3:00 PM CDT. This notice does not obligate the VA to issue a solicitation.
    Pharmaceutical Repackaging Services for National CMOP (770)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for pharmaceutical repackaging services for the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The contract, identified as 36C77026R0004, is a firm-fixed-price, indefinite-delivery agreement intended to support the repackaging of government-purchased oral solid pharmaceuticals into various bottle sizes for distribution to over 7 million veterans. The contract spans a five-year ordering period from February 1, 2026, to January 31, 2031, with a potential six-month extension, and has a minimum value of $20 million and a maximum value of $125 million. Interested contractors should contact Renee Kreutzer at renee.kreutzer@va.gov for further details and must submit their proposals by the specified deadlines, ensuring compliance with all relevant regulations and standards.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/ Uniform Formulary Additional Discount Program
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is soliciting quotes for a Blanket Purchase Agreement (BPA) and an Additional Discount Program (ADP) for pharmaceutical agents to be included in the DoD Uniform Formulary (UF). This procurement aims to establish an effective pharmacy benefits program for the Military Health System (MHS), focusing on oncological agents for myelofibrosis and antihemophilic agents, with evaluations based on clinical and cost-effectiveness. Interested vendors must submit their quotes by January 16, 2026, with a pre-quotation teleconference scheduled for November 20, 2025. For further inquiries, contact Tracy Banks at tracy.e.banks2.civ@health.mil or Stephanie Erpelding at stephanie.j.erpelding.civ@health.mil.
    6505--LANSOPRAZOLE
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure Lansoprazole, a pharmaceutical product, for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). This procurement is justified as a sole source requirement, indicating that Lansoprazole is essential for the pharmacy's operations and patient care. The drug falls under the category of drugs and biologicals, highlighting its critical role in treating various medical conditions. Interested vendors can reach out to Contract Specialist Brigitte Kidder at Brigitte.Kidder@va.gov or by phone at 913-946-0150 for further details regarding this opportunity.